McDowall Rd
McDowall Consulting, 73 Murray Avenue, Bromley, Kent, BR1 3DJ, UK.
Bioanalysis. 2011 Jul;3(13):1487-99. doi: 10.4155/bio.11.138.
Computerized system validation is often viewed as a burden and a waste of time to meet regulatory requirements. This article presents a different approach by looking at validation in a bioanalytical laboratory from the business benefits that computer validation can bring. Ask yourself the question, have you ever bought a computerized system that did not meet your initial expectations? This article will look at understanding the process to be automated, the paper to be eliminated and the records to be signed to meet the requirements of the GLP or GCP and Part 11 regulations. This paper will only consider commercial nonconfigurable and configurable software such as plate readers and LC-MS/MS data systems rather than LIMS or custom applications. Two streamlined life cycle models are presented. The first one consists of a single document for validation of nonconfigurable software. The second is for configurable software and is a five-stage model that avoids the need to write functional and design specifications. Both models are aimed at managing the risk each type of software poses whist reducing the amount of documented evidence required for validation.
计算机化系统验证通常被视为一种负担,是为满足监管要求而浪费时间。本文提出了一种不同的方法,即从计算机验证所能带来的商业利益的角度审视生物分析实验室中的验证。问问你自己,你是否曾购买过不符合你最初期望的计算机化系统?本文将探讨理解待自动化的流程、待消除的纸质文件以及为满足GLP或GCP及第11部分法规要求而需签署的记录。本文仅考虑诸如酶标仪和液相色谱 - 串联质谱数据系统等商业非可配置和可配置软件,而非实验室信息管理系统(LIMS)或定制应用程序。文中介绍了两种简化的生命周期模型。第一种由一份用于非可配置软件验证的单一文档组成。第二种针对可配置软件,是一个五阶段模型,无需编写功能和设计规范。这两种模型旨在管理每种类型软件所带来的风险,同时减少验证所需的文件证据量。